Abstract
Retinoblastoma protein-interacting zinc-finger gene 1 (RIZ1), a strong tumor suppressor, is silenced in many human cancers. Our previous studies showed that RIZ1 expression was negatively correlated with the grade of glioma and was a key predictor of patient survival. Therefore, RIZ1 could be a potential tumor suppressor during glioma pathogenesis, although the mechanism underlying RIZ1 gene inactivation in gliomas is unknown. We investigated the methylation status of the RIZ1 promoter in human glioma tissues and four glioblastoma (GBM) cell lines, and verified the effect of the methyltransferase inhibitor 5-aza-2-deoxycytidine (5-aza-CdR) on RIZ1 transcription and cell proliferation. Methylation-specific PCR (MSP) was performed to determine RIZ1 promoter methylation in human glioma specimens. The correlation between RIZ1 hypermethylation in tumors and clinicopathological features also was analyzed. 5-Aza-CdR treatment was used to reactivate gene expression silenced by hypermethylation in the U87 glioblastoma cell line, and real-time PCR was then used to measure RIZ1 expression. The ability of 5-aza-CdR to inhibit the proliferation of glioma cell lines whose RIZ1 promoters were hypermethylated was measured by bromodeoxyuridine (BrdU) incorporation. Among 51 human glioma specimens, RIZ1 promoter methylation was detected in 23 cases. Clinicopathological evaluation suggested that RIZ1 hypermethylation was negatively associated with tumor grade and patient age (P < 0.05). Hypermethylation of the RIZ1 promoter was detected in the U87 and U251 cell lines. RIZ1 mRNA expression in U87 cells was upregulated after treatment with 5-aza-Cdr, which correlated with inhibition of cell proliferation in a time- and concentration-dependent manner. Promoter hypermethylation may play an important role in the epigenetic silencing of RIZ1 expression in human glioma tissues and GBM cell lines.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alonso ME et al (2005) Mutational study of the 1p located genes p18ink4c, Patched-2, RIZ1 and KIF1B in oligodendrogliomas. Oncol Rep 13:539–542
Borodovsky A et al (2013) 5-Azacytidine reduces methylation, promotes differentiation and induces tumor regression in a patient-derived IDH1 mutant glioma xenograft. Oncotarget 4:1737–1747
Chiam K, Centenera MM, Butler LM, Tilley WD, Bianco-Miotto T (2011) GSTP1 DNA methylation and expression status is indicative of 5-aza-2′-deoxycytidine efficacy in human prostate cancer cells. Plos ONE 6:e25634
Dong SW et al (2012a) Decreased expression of retinoblastoma protein-interacting zinc-finger gene 1 in human esophageal squamous cell cancer by DNA methylation. Clin Lab 58:41–51
Dong SW et al (2012b) Study on RIZ1 gene promoter methylation status in human esophageal squamous cell carcinoma. World J Gastroenterol 18:576–582
Dong S, Zhang P, Liang S, Wang S, Sun P, Wang Y (2013) The role of the retinoblastoma protein-interacting zinc finger gene 1 tumor suppressor gene in human esophageal squamous cell carcinoma cells. Oncol Lett 6:1656–1662
Du Y, Carling T, Fang W, Piao Z, Sheu JC, Huang S (2001) Hypermethylation in human cancers of the RIZ1 tumor suppressor gene, a member of a histone/protein methyltransferase superfamily. Cancer Res 61:8094–8099
Hasegawa Y et al (2007) DNA methylation of the RIZ1 gene is associated with nuclear accumulation of p53 in prostate cancer. Cancer Sci 98:32–36
Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB (1996) Methylation specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93:9821–9826
Hutajulu SH et al (2011) Epigenetic markers for early detection of nasopharyngeal carcinoma in a high risk population. Mol Cancer 10:48
Jackson-Grusby L, Laird PW, Magge SN, Moeller BJ, Jaenisch R (1997) Mutagenicity of 5-aza-2′-deoxycytidine is mediated by the mammalian DNA methyltransferase. Proc Natl Acad Sci USA 94:4681–4685
Jiang GL, Huang S (2001) Adenovirus expressing RIZ1 in tumor suppressor gene therapy of microsatellite-unstable colorectal cancers. Cancer Res 61:1796–1798
Li H et al (2014) Immune regulation by low doses of the DNA methyltransferase inhibitor 5-azacitidine in common human epithelial cancers. Oncotarget 5:587–598
Missiaglia E, Donadelli M, Palmieri M, Crnogorac-Jurcevic T, Scarpa A, Lemoine NR (2005) Growth delay of human pancreatic cancer cells by methylase inhibitor 5-aza-2′-deoxycytidine treatment is associated with activation of the interferon signalling pathway. Oncogene 24:199–211
Momparler RL, Ayoub J (2001) Potential of 5-aza-2′-deoxycytidine (decitabine) a potent inhibitor of DNA methylation for therapy of advanced non-small cell lung cancer. Lung Cancer 34:S111–S115
Oshimo Y et al (2004) Frequent epigenetic inactivation of RIZ1 by promoter hypermethylation in human gastric carcinoma. Int J Cancer 110:212–218
Poetsch M, Dittberner T, Woenckhaus C (2002) Frameshift mutations of RIZ, but no point mutations in RIZ1 exons in malignant melanomas with deletions in 1p36. Oncogene 21:3038–3042
Samlowski WE et al (2005) Evaluation of a 7-day continuous intravenous infusion of decitabine: inhibition of promoter-specific and global genomic DNA methylation. J Clin Oncol 23:3897–3905
Santini V, Kantarjian HM, Issa JP (2001) Changes in DNA methylation in neoplasia: pathophysiology and therapeutic implications. Ann Intern Med 134:573–586
Shimura H, Mori N, Wang YH, Okada M, Motoji T (2012) Aberrant methylation and decreased expression of the RIZ1 gene are frequent in adult acute lymphoblastic leukemia of T-cell phenotype. Leuk Lymphoma 53:1599–1609
Tsai HC et al (2012) Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells. Cancer Cell 21:430–446
Zhang C et al (2015) RIZ1: a potential tumor suppressor in glioma. BMC Cancer 15:990
Acknowledgments
This work was generously supported by the National Natural Sciences Fund Project of China (NSFC Nos. 81500601), Shanghai Municipal Natural Science Foundation (14ZR1413800), Shanghai Municipal Health Bureau Project (201440383), and Foundation for Youths of Changzheng Hospital (2012CZQN05).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing Interests
The authors declare that they do not have any financial or non-financial competing interests.
Additional information
Chenran Zhang, Wei Meng and Jiajia Wang contributed equally to this work.
Rights and permissions
About this article
Cite this article
Zhang, C., Meng, W., Wang, J. et al. Methylation Status of the RIZ1 Gene Promoter in Human Glioma Tissues and Cell Lines. Cell Mol Neurobiol 37, 1021–1027 (2017). https://doi.org/10.1007/s10571-016-0435-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10571-016-0435-3